This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Terremoto Biosciences, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jordan D. Carelli: Innovator in Pharmaceutical Modulation
Introduction
Jordan D. Carelli is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of AKT1, a crucial protein involved in various cellular processes.
Latest Patents
Jordan D. Carelli holds 2 patents. His latest patents include "Non-covalent modifiers of AKT1 and uses thereof," which provides non-covalent modifiers of AKT1 and pharmaceutical compositions for modulating wild-type AKT1. Another significant patent is "Cysteine covalent modifiers of AKT1 and uses thereof," which focuses on the development of cysteine covalent modifiers for AKT1.
Career Highlights
Jordan is currently associated with Terremoto Biosciences, Inc., where he applies his expertise in pharmaceutical innovation. His work is pivotal in advancing therapeutic strategies that target AKT1, which has implications for various diseases.
Collaborations
He collaborates with esteemed colleagues, including Kin S. Yang and Peter A. Thompson, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jordan D. Carelli's work exemplifies the intersection of innovation and pharmaceutical science, making strides in the modulation of critical proteins for therapeutic applications. His contributions are shaping the future of drug development and treatment strategies.